National Bank of Canada’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

National Bank of Canada’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,600	Closed	-$520	–	2924
2023 Q2	$520	Hold	2,600	–	–	﹤0.01%	2608
2023 Q1	$393	Hold	2,600	–	–	﹤0.01%	2603
2022 Q4	$1.44K	Hold	2,600	–	–	﹤0.01%	2541
2022 Q3	$3K	Hold	2,600	–	–	﹤0.01%	2476
2022 Q2	$2K	Hold	2,600	–	–	﹤0.01%	2654
2022 Q1	$3K	Hold	2,600	–	–	﹤0.01%	2681
2021 Q4	$6K	Buy	+2,600	New	+$6.53K	﹤0.01%	2514

Other funds holding INFI

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

National Bank of Canada's INFI Position: Q3 2023 in Review

National Bank of Canada sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 2,600 shares — an estimated $520 sold.

National Bank of Canada first reported a position in INFI in Q4 2021 and held it in 7 quarters. The position peaked at $6K in Q4 2021. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.

National Bank of Canada reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
National Bank of Canada sold 2,600 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $520.
National Bank of Canada first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2021 and held it in 7 quarters.
National Bank of Canada's Infinity Pharmaceuticals, Inc. position peaked at $6K in Q4 2021.
3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.

Based on National Bank of Canada's 13F filing for Q3 2023, filed 10 Oct 2023.